Alteration in the magnitude of induction of tyrosine transaminase by glycocorticoids. The effects of phenobarbital, o,p'DDD and beta-diethylaminoethyl diphenylpropylacetate (SKF 525A).
D000818:Animals; D003864:Depression, Chemical; D003632:Dichlorodiphenyldichloroethane / Q000494:pharmacology*; D004357:Drug Synergism; D004790:Enzyme Induction; D006854:Hydrocortisone / Q000494:pharmacology*; D008099:Liver / Q000201:enzymology*; D008297:Male; D010634:Phenobarbital / Q000494:pharmacology*; D011335:Proadifen / Q000494:pharmacology*; D051381:Rats; D013268:Stimulation, Chemical; D013997:Time Factors; D014221:Triamcinolone / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014222:Triamcinolone Acetonide / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014316:Tritium; D014444:Tyrosine Transaminase / Q000096:biosynthesis*
D014316:Tritium; D014221:Triamcinolone; D011335:Proadifen; D014444:Tyrosine Transaminase; D014222:Triamcinolone Acetonide; D003632:Dichlorodiphenyldichloroethane; D006854:Hydrocortisone; D010634:Phenobarbital